CD274 and non-small cell lung carcinoma: In a case report, both regional and abscopal response were obtained after combining PD-1 inhibitor and SBRT treatments in three advanced or recurrent NSCLC patients with low TMB, microsatellite stable (MSS), proficient mismatch repair (MMR), and negative PD-L1 expression (131).